[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naïve HIV-1 infected adolescents and children aged ≥6 to <18 years

What is the purpose of the study? (in Layman's terms, please describe the study)

Doctor Leonard B Weiner, MD is doing this study for the sponsor. An independent ethics committee or institutional review board has approved the study.
Research studies are done to find out the best way to treat patients. Research studies may test drugs or other types of treatments.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:


Study Phase:

Phase II

Patient Age Group:


Principal Investigator:

Leonard B Weiner

Who can I contact for more information?

Name: Wendy A Holz
Phone: 315-464-7562
Email: holzw@upstate.edu

Return to Previous Page || Search Again